Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Transfusion-Dependent”

223 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 223 results

Early research (Phase 1)Ended earlyNCT01034592
What this trial is testing

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Who this might be right for
AnemiaLeukemiaAcute Myeloid Leukemia (AML)+1 more
Jason Robert Gotlib 2
Post-approval studies (Phase 4)Study completedNCT06606886
What this trial is testing

Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia

Who this might be right for
Transfusion Dependent Beta-thalassemia
Bahria University 96
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Not applicableNot Yet RecruitingNCT06964971
What this trial is testing

Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study

Who this might be right for
Transfusion-dependent Non-severe Aplastic Anemia
The First Affiliated Hospital of Zhejiang Chinese Medical University 90
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Not applicableNot Yet RecruitingNCT06743113
What this trial is testing

Hypoxic Red Blood Cells in Sickle Cell Anemia

Who this might be right for
Sickle Cell AnaemiaSickle Cell Anemia CrisisSickle Cell Anemia in Children+1 more
Hemanext 48
Not applicableLooking for participantsNCT05991336
What this trial is testing

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Who this might be right for
Transfusion-dependent Beta-ThalassemiaGene Therapy
Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)Study completedNCT01178814
What this trial is testing

Revlimid in Transfusion Dependent Patients

Who this might be right for
Myelodysplastic Syndrome
Columbia University 57
Testing effectiveness (Phase 2)Study completedNCT01709032
What this trial is testing

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Who this might be right for
Thalassemia Major With Severe Transfusional Iron Overload
Children's Hospital of Philadelphia 9
Not applicableNot Yet RecruitingNCT07660224
What this trial is testing

The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia

Who this might be right for
Beta-Thalassemia MajorTransfusion-Dependent Thalassemia
Oman Ministry of Health 45
Testing effectiveness (Phase 2)Looking for participantsNCT07680803
What this trial is testing

Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Fondazione Telethon 9
Post-approval studies (Phase 4)Study completedNCT06299670
What this trial is testing

Efficacy of Combination of Hdroxyurea and Thalidomide Over Hydroxyurea or Thalidomide in the Treatment of Transfusion Dependent Thalassemia in Children

Who this might be right for
Transfusion-dependent Thalassemia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90
Testing effectiveness (Phase 2)Study completedNCT00873041
What this trial is testing

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Who this might be right for
Non-transfusion Dependent Thalassemia
Novartis Pharmaceuticals 166
Not applicableLooking for participantsNCT06270771
What this trial is testing

OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

Who this might be right for
MDSMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms+1 more
Sunnybrook Health Sciences Centre 60
Large-scale testing (Phase 3)Study completedNCT03651102
What this trial is testing

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

Who this might be right for
Thalassemia
Blood Diseases Clinic 654
Not applicableEnded earlyNCT05752123
What this trial is testing

Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 2
Not applicableActive Not RecruitingNCT05860595
What this trial is testing

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Study completedNCT02435212
What this trial is testing

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Who this might be right for
Transfusion-dependent Anemia
Novartis Pharmaceuticals 224
Testing effectiveness (Phase 2)Study completedNCT01338337
What this trial is testing

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia

Who this might be right for
Myelodysplastic Syndrome (MDS)
Asociación Andaluza de Hematología y Hemoterapia 40
Next Page